RC

Rajkumar Chidambarao Patil

Director DIN 07044564
DIN 07044564 First appointment Jan 2015
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajkumar Chidambarao Patil

Data last updated:

Rajkumar Chidambarao Patil was a Director at Trusmed Healthcare Private Limited (from 2015) and Director at Dr. Resq Laboratories Private Limited (from 2017).

DIN 07044564
First Appointment 13 Jan 2015
Oldest Company Age 11 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Trusmed Healthcare Private Limited U51909KA2015PTC078277
Director13 Jan 20152015₹22.8 Lakh (FY 2016)Strike Off
Director22 May 20172017₹2.4 Lakh (FY 2018)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Trusmed Healthcare Private Limited
Dr. Resq Laboratories Private Limited
Premium access

Shareholding and investment profile for Rajkumar Chidambarao Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajkumar Chidambarao Patil

Rajkumar Chidambarao Patil was first appointed on 13 Jan 2015 as Director at Trusmed Healthcare Private Limited. The most recent appointment on record is 22 May 2017 at Dr. Resq Laboratories Private Limited.

Rajkumar Chidambarao Patil held 2 earlier board appointments: Trusmed Healthcare Private Limited (Director, from 13 Jan 2015); Dr. Resq Laboratories Private Limited (Director, from 22 May 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available